Skip to main content
Skip to main content
HSHL logo

Home Solutions Health Inc. (HSHL) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED

What happened to Home Solutions Health Inc. (HSHL) stock?

Home Solutions Health Inc. (HSHL) no longer trades on public markets. The figures below are historical and are not a current quote.

Vol: 14.0K| 52-wk range: $0.000001 – $0.000001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Home Solutions Health Inc. (HSHL). Home Solutions Health Inc. focuses on the manufacturing, marketing, and sale of healthcare products, specifically Hemorrelief. The company operates in the Other Precious Metals industry within the Basic Materials sector. Sector: Basic materials.

Last analyzed: Mar 16, 2026
Home Solutions Health Inc. focuses on the manufacturing, marketing, and sale of healthcare products, specifically Hemorrelief. The company operates in the Other Precious Metals industry within the Basic Materials sector.

Analyst Coverage for HSHL: HSHL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HSHL against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the HSHL film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 49/100 · C

HSHL: the 2 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Unfavorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Home Solutions Health Inc. (HSHL) Materials & Commodity Exposure

HeadquartersHouston, US
IPO Year2000

Home Solutions Health Inc. manufactures and markets healthcare products, primarily Hemorrelief, operating within the niche Other Precious Metals industry. Founded in 1996, the company faces challenges typical of OTC-listed entities, including liquidity and disclosure risks, while navigating a competitive landscape with established players in the broader healthcare sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for HSHL?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Investing in Home Solutions Health Inc. (HSHL) presents a high-risk, high-reward scenario given its OTC listing and limited product line. The company's focus on Hemorrelief offers a niche market opportunity, but its success depends heavily on effective marketing and distribution. Key value drivers include potential revenue growth from increased market penetration and successful product line expansion. However, the company's OTC status introduces liquidity and disclosure risks. The high beta of 7.34 indicates significant volatility. Investors should carefully consider the risks associated with HSHL's OTC listing and limited financial information before investing.

Based on FMP financials and quantitative analysis

HSHL Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Home Solutions Health Inc. operates in the healthcare sector, focusing on manufacturing and marketing products like Hemorrelief.

  • The company was founded in 1996 and is headquartered in New York, NY.
  • HSHL's market capitalization is $0.00B, indicating its small size within the Basic Materials sector.
  • The stock has a high beta of 7.34, suggesting significant volatility compared to the overall market.
  • HSHL does not currently offer a dividend, which may deter income-focused investors.

Who Are HSHL's Competitors?

HSHL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
JSCPY JSR Corporation $25.26 +1.04%
AHNRF Athena Gold Corporation $0.42 +3.41% $15.2M
FSTTF First Tellurium Corp. $0.22 +6.28% $28.9M 429-signal
VIPRF Silver Viper Minerals Corp. $0.33 -6.00% $39.4M 469-signal
EQMEF Equity Metals Corporation $0.17 -7.82% $41.6M 489-signal
ACKRF American Creek Resources Ltd. $0.11 +3.64% $54.2M
AGMRF Silver Mountain Resources Inc. $2.80 -6.85% $62.4M 499-signal
HBEIF Honey Badger Silver Inc. $0.46 -6.26% $75.6M 429-signal

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HSHL's Key Strengths?

Focus on a specific healthcare product (Hemorrelief).

  • Established presence in the healthcare market (since 1996).
  • Potential for brand recognition in its niche.
  • Simple business model.

What Are HSHL's Weaknesses?

Limited product line.

  • Small market capitalization ($0.00B).
  • OTC listing (liquidity and disclosure risks).
  • High beta (7.34) indicating high volatility.

What Could Drive HSHL Stock Higher?

Potential product line expansion to address broader healthcare needs.

  • Strategic partnerships to expand market reach and distribution channels.
  • Investment in online marketing and e-commerce to reach a global audience.

What Are the Key Risks for HSHL?

Competition from larger, more established healthcare companies.

  • Regulatory changes in the healthcare industry.
  • Economic downturn affecting consumer spending.
  • Limited financial disclosure due to OTC listing.
  • Low liquidity and wide bid-ask spreads.

What Are the Growth Opportunities for HSHL?

  • Expansion of Product Line: Home Solutions Health Inc. has the opportunity to expand its product line beyond Hemorrelief to address other healthcare needs. By diversifying its offerings, the company can attract a broader customer base and reduce its reliance on a single product. The market for healthcare products is vast, with a global market size estimated at trillions of dollars. Successful product diversification could significantly increase HSHL's revenue and market share. Timeline: 2-3 years.
  • Strategic Partnerships: Forming strategic partnerships with established healthcare distributors and retailers can significantly expand Home Solutions Health's market reach. By leveraging the existing distribution networks of larger companies, HSHL can gain access to a wider customer base and increase sales. The healthcare distribution market is highly competitive, but strategic alliances can provide smaller companies with a significant advantage. Timeline: 1-2 years.
  • Online Marketing and E-commerce: Investing in online marketing and e-commerce platforms can enable Home Solutions Health to reach a global audience and increase sales. By developing a user-friendly website and implementing effective digital marketing strategies, HSHL can attract new customers and build brand awareness. The e-commerce market for healthcare products is growing rapidly, offering significant opportunities for companies with a strong online presence. Timeline: Ongoing.
  • Geographic Expansion: Expanding into new geographic markets can provide Home Solutions Health with significant growth opportunities. By targeting regions with unmet healthcare needs and limited competition, HSHL can increase its sales and market share. The global healthcare market is vast and diverse, with significant opportunities for companies that can effectively adapt their products and marketing strategies to local conditions. Timeline: 3-5 years.
  • Research and Development: Investing in research and development can enable Home Solutions Health to develop innovative new products and improve its existing offerings. By staying at the forefront of healthcare innovation, HSHL can maintain a competitive edge and attract new customers. The healthcare industry is constantly evolving, with new technologies and treatments emerging regularly. Companies that invest in R&D are better positioned to capitalize on these trends. Timeline: Ongoing.

What Are HSHL's Competitive Advantages?

  • Niche product focus (Hemorrelief).
  • Established brand name (limited information to assess strength).
  • Proprietary formulations (unconfirmed).

What Does HSHL Do?

Home Solutions Health Inc., established in 1996, is a manufacturer and marketer of healthcare products. The company's primary offering is Hemorrelief, a product focused on a specific healthcare need. Headquartered in New York, NY, Home Solutions Health operates within the Basic Materials sector, specifically in the Other Precious Metals industry. The company's business model centers around the production and distribution of its healthcare product, targeting consumers seeking relief from specific ailments. As a smaller player in the broader healthcare market, Home Solutions Health faces competition from larger, more established companies with diversified product portfolios and greater market reach. The company's success hinges on its ability to effectively market and distribute Hemorrelief, while navigating the challenges associated with operating as an OTC-listed entity.

What Products and Services Does HSHL Offer?

  • Manufactures healthcare products.
  • Markets healthcare products.
  • Sells healthcare products.
  • Offers Hemorrelief, a specific healthcare product.
  • Operates within the Basic Materials sector.
  • Focuses on the Other Precious Metals industry.

How Does HSHL Make Money?

  • Manufactures Hemorrelief and other healthcare products.
  • Markets and sells products directly to consumers or through distributors.
  • Generates revenue through product sales.

What Industry Does HSHL Operate In?

Home Solutions Health Inc. operates within the Other Precious Metals industry, a niche segment of the broader Basic Materials sector. This industry is characterized by companies involved in the extraction, processing, and application of precious metals in various products, including healthcare. The competitive landscape includes companies like CADIF, COLUF, GTBT, JSCPY, and MSLM. Market trends in the healthcare sector include increasing demand for specialized healthcare products and growing consumer awareness of health and wellness. Home Solutions Health's success depends on its ability to differentiate its product and effectively compete with larger, more established players.

Who Are HSHL's Key Customers?

  • Individuals seeking relief from specific ailments.
  • Healthcare distributors.
  • Retailers of healthcare products.
Model self-rating on this text: 67% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low 12/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price 5 days old
  • No filing on record
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 4 snapshots

2026-08-23 44
2026-08-24 44
2026-08-25 44
2026-08-26 44

What changed?

The score has stayed at 44.

Over the same 3 days the stock moved +0.0%.

Company Profile

Home Solutions Health Inc. operates in the Other Precious Metals industry within the Basic Materials sector. It is headquartered in Houston, US. HSHL has traded publicly since 2000.

HSHL Financials

Bull Case vs Bear Case

Bull Case

  • Focus on a specific healthcare product (Hemorrelief).
  • Established presence in the healthcare market (since 1996).
  • Potential for brand recognition in its niche.
  • Simple business model.

Bear Case

  • Limited product line.
  • Small market capitalization ($0.00B).
  • OTC listing (liquidity and disclosure risks).
  • High beta (7.34) indicating high volatility.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

HSHL Latest News

HSHL OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for trading on OTCQX or OTCQB. Companies in this tier often face challenges such as limited financial disclosure, lack of regulatory oversight, and potential shell risk. Investing in OTC Other securities carries significant risks due to the limited information available and the potential for fraud or manipulation. These securities may not meet minimum financial standards or have undergone thorough due diligence.

Shell Risk: This security has been flagged for shell risk by OTC Markets.
  • OTC Tier: OTC Other
Liquidity: As an OTC-listed stock, HSHL likely suffers from low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares quickly and at desired prices. The limited liquidity can result in significant price fluctuations and increased transaction costs. Investors should be aware of the potential challenges associated with trading HSHL on the OTC market.
OTC Risk Factors:
  • Limited financial disclosure.
  • Low liquidity and wide bid-ask spreads.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight.
  • Shell risk detected.
Due Diligence Checklist:
  • Verify the company's financial statements (if available).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Determine the company's ownership structure.
  • Check for any red flags or warning signs.
  • Consult with a qualified financial advisor.
Legitimacy Signals:
  • Company has been in business since 1996.
  • Company manufactures and sells a tangible product (Hemorrelief).
  • Company is headquartered in New York, NY.

What Investors Ask About Home Solutions Health Inc. (HSHL) — Basic Materials

What happened to Home Solutions Health Inc. (HSHL) stock?

Home Solutions Health Inc. (HSHL) no longer trades on public markets. The figures below are historical and are not a current quote.

Can I still buy HSHL shares?

No. HSHL stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HSHL elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before HSHL stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Home Solutions Health Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Home Solutions Health Inc. do?

Home Solutions Health Inc. is a manufacturer and marketer of healthcare products, primarily focusing on Hemorrelief. Operating within the Basic Materials sector and the Other Precious Metals industry, the company's business model centers on producing and distributing its healthcare product to consumers seeking relief from specific ailments.

What do analysts say about HSHL stock?

Currently, there is no available analyst coverage for Home Solutions Health Inc. (HSHL). This lack of coverage is typical for OTC-listed companies with small market capitalizations.

What are the main risks for HSHL?

The main risks for Home Solutions Health Inc. include its OTC listing, which entails limited financial disclosure, low liquidity, and potential for manipulation.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available for Home Solutions Health Inc. due to its OTC listing.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover